BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party - Poll - MDSpire

BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

  • By

  • Raffaella Greco

  • Riccardo Saccardi

  • Marta Ponzano

  • Manuela Badoglio

  • Grzegorz Helbig

  • Marek Smilowski

  • Alice Mariottini

  • Joachim Burman

  • Kristina Carlson

  • Majid Kazmi

  • Paolo A. Muraro

  • Ian Gabriel

  • Barbara Withers

  • Jennifer Massey

  • Riccardo Varaldo

  • Matilde Inglese

  • Jaime Sanz

  • Sara Gil-Perotin

  • Basil Sharrack

  • Elisa Roldan

  • Chiara Nozzoli

  • Alessio Signori

  • Maria Pia Sormani

  • Tobias Alexander

  • John A. Snowden

  • September 29, 2025

  • 0 min

Share

Original Source(s)

BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party

  • by Raffaella Greco, Riccardo Saccardi, Marta Ponzano, Manuela Badoglio, Grzegorz Helbig, Marek Smilowski, Alice Mariottini, Joachim Burman, Kristina Carlson, Majid Kazmi, Paolo A. Muraro, Ian Gabriel, Barbara Withers, Jennifer Massey, Riccardo Varaldo, Matilde Inglese, Jaime Sanz, Sara Gil-Perotin, Basil Sharrack, Elisa Roldan, Chiara Nozzoli, Alessio Signori, Maria Pia Sormani, Tobias Alexander, John A. Snowden

  • September 29, 2025

Related Content

OBITUARY- Riccardo Saccardi (20th April 1956–19th February 2024)

BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis

The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis